|
May 24, 2022 |
May 23, 2022 |
B
Purchase
|
Seyedkazemi Setareh
Chief Development Officer
Officer
|
20,000
+3333.3%
0.84
16,800
USD
|
20,000
+3333.3%
|
0.84
|
16,800
USD
|
|
|
May 19, 2022 |
May 17, 2022 |
B
Purchase
|
Beckman Richard
Chief Medical Officer
Officer
|
10,000
+inf%
0.82
8,228
USD
|
10,000
+inf%
|
0.82
|
8,228
USD
|
|
|
May 17, 2022 |
May 17, 2022 |
B
Purchase
|
D'Souza Rupert
Chief Financial Officer
Officer
|
10,000
+92.2%
0.83
8,272
USD
|
10,000
+92.2%
|
0.83
|
8,272
USD
|
|
|
May 18, 2022 |
May 16, 2022 |
B
Purchase
|
Svoronos Dawn
Non-Executive Director
|
30,000
+150.0%
0.85
25,578
USD
|
30,000
+150.0%
|
0.85
|
25,578
USD
|
|
|
May 17, 2022 |
May 13, 2022 |
B
Purchase
|
D'Souza Rupert
Chief Financial Officer
Officer
|
10,000
+1176.5%
0.86
8,585
USD
|
10,000
+1176.5%
|
0.86
|
8,585
USD
|
|
|
April 22, 2022 |
April 20, 2022 |
B
Purchase
|
Fischer Laurent
CEO, President and Director
Executive Director
|
25,000
+3.4%
1.11
27,800
USD
|
25,000
+3.4%
|
1.11
|
27,800
USD
|
|
|
April 20, 2022 |
April 19, 2022 |
B
Purchase
|
Soparkar Peter
See Remarks section
Officer
|
21,750
+8.4%
1.14
24,795
USD
|
21,750
+8.4%
|
1.14
|
24,795
USD
|
|
|
April 20, 2022 |
April 19, 2022 |
B
Purchase
|
Soparkar Peter
See Remarks section
Officer
|
175
+0.1%
1.14
199
USD
|
175
+0.1%
|
1.14
|
199
USD
|
|
|
Dec. 10, 2021 |
Dec. 9, 2021 |
B
Purchase
|
Fischer Laurent
CEO, President and Director
Executive Director
|
14,323
+2.0%
1.85
26,498
USD
|
14,323
+2.0%
|
1.85
|
26,498
USD
|
|
|
Dec. 10, 2021 |
Dec. 8, 2021 |
PP
Planned purchase
|
Fischer Laurent
CEO, President and Director
Executive Director
|
10,677
+1.5%
1.79
19,112
USD
|
10,677
+1.5%
|
1.79
|
19,112
USD
|
|
|
Dec. 10, 2021 |
Dec. 8, 2021 |
PP
Planned purchase
|
Soparkar Peter
See Remarks section
Officer
|
25,000
+10.7%
1.91
47,750
USD
|
25,000
+10.7%
|
1.91
|
47,750
USD
|
|
|
Nov. 17, 2021 |
Nov. 15, 2021 |
S
Sale
|
Scopa James Paul
Non-Executive Director
|
50,000
-93.7%
2.18
109,000
USD
|
50,000
-93.7%
|
2.18
|
109,000
USD
|
|
|
Oct. 4, 2021 |
Sept. 30, 2021 |
S
Sale
|
Clark Julie
Chief Medical Officer
Officer
|
4,766
-2.8%
2.17
10,342
USD
|
4,766
-2.8%
|
2.17
|
10,342
USD
|
|
|
April 1, 2021 |
March 31, 2021 |
B
Purchase
|
Svoronos Dawn
Non-Executive Director
|
20,000
+inf%
10.02
200,338
USD
|
20,000
+inf%
|
10.02
|
200,338
USD
|
|
|
March 24, 2021 |
March 24, 2021 |
B
Purchase
|
Machado Patrick
Non-Executive Director
|
10,000
+12.8%
9.92
99,196
USD
|
10,000
+12.8%
|
9.92
|
99,196
USD
|
|
|
March 24, 2021 |
March 24, 2021 |
B
Purchase
|
Fischer Laurent
CEO and Director
Executive Director
|
10,000
+61.4%
9.88
98,780
USD
|
10,000
+61.4%
|
9.88
|
98,780
USD
|
|
|
Feb. 11, 2021 |
Feb. 9, 2021 |
S
Sale
|
PATTERSON LEONE D
President and CFO
Officer
|
62
-0.1%
14.14
877
USD
|
62
-0.1%
|
14.14
|
877
USD
|
|
|
Feb. 11, 2021 |
Feb. 9, 2021 |
S
Sale
|
PATTERSON LEONE D
President and CFO
Officer
|
12,471
-11.3%
14.10
175,841
USD
|
12,471
-11.3%
|
14.10
|
175,841
USD
|
|
|
Jan. 19, 2021 |
Jan. 15, 2021 |
B
Purchase
|
Machado Patrick
Non-Executive Director
|
10,000
+14.7%
11.52
115,174
USD
|
10,000
+14.7%
|
11.52
|
115,174
USD
|
|
|
Jan. 19, 2021 |
Jan. 15, 2021 |
B
Purchase
|
Fischer Laurent
CEO and Director
Executive Director
|
8,600
+111.8%
11.53
99,191
USD
|
8,600
+111.8%
|
11.53
|
99,191
USD
|
|
|
Aug. 19, 2020 |
Aug. 17, 2020 |
PP
Planned purchase
|
Soparkar Peter
Chief Legal Officer
Officer
|
7,692
+256.4%
13.00
99,996
USD
|
7,692
+256.4%
|
13.00
|
99,996
USD
|
|
|
Aug. 19, 2020 |
Aug. 17, 2020 |
B
Purchase
|
Fischer Laurent
CEO and Director
Executive Director
|
7,692
+inf%
13.00
99,996
USD
|
7,692
+inf%
|
13.00
|
99,996
USD
|
|
|
July 22, 2020 |
July 20, 2020 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
5,000
-1.8%
17.60
87,978
USD
|
5,000
-1.8%
|
17.60
|
87,978
USD
|
|
|
June 23, 2020 |
June 22, 2020 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
23,605
-7.9%
25.06
591,617
USD
|
23,605
-7.9%
|
25.06
|
591,617
USD
|
|
|
June 18, 2020 |
June 18, 2020 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
11,127
-3.9%
25.01
278,329
USD
|
11,127
-3.9%
|
25.01
|
278,329
USD
|
|
|
June 18, 2020 |
June 17, 2020 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
268
-0.1%
25.01
6,703
USD
|
268
-0.1%
|
25.01
|
6,703
USD
|
|
|
June 17, 2020 |
June 16, 2020 |
S
Sale
|
PATTERSON LEONE D
President
Officer
|
13,171
-10.7%
24.68
325,060
USD
|
13,171
-10.7%
|
24.68
|
325,060
USD
|
|
|
June 17, 2020 |
June 15, 2020 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
159
-0.1%
23.59
3,751
USD
|
159
-0.1%
|
23.59
|
3,751
USD
|
|
|
June 17, 2020 |
June 15, 2020 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
3,425
-1.2%
23.00
78,787
USD
|
3,425
-1.2%
|
23.00
|
78,787
USD
|
|
|
June 17, 2020 |
June 15, 2020 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
1,416
-0.5%
21.93
31,047
USD
|
1,416
-0.5%
|
21.93
|
31,047
USD
|
|
|
June 17, 2020 |
June 15, 2020 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
5,000
-1.8%
21.01
105,042
USD
|
5,000
-1.8%
|
21.01
|
105,042
USD
|
|
|
May 22, 2020 |
May 20, 2020 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
1,401
-0.5%
20.01
28,030
USD
|
1,401
-0.5%
|
20.01
|
28,030
USD
|
|
|
May 20, 2020 |
May 18, 2020 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
300
-0.1%
19.03
5,709
USD
|
300
-0.1%
|
19.03
|
5,709
USD
|
|
|
May 20, 2020 |
May 18, 2020 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
4,700
-1.7%
18.11
85,124
USD
|
4,700
-1.7%
|
18.11
|
85,124
USD
|
|
|
May 20, 2020 |
May 6, 2020 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
25,000
-8.3%
20.03
500,668
USD
|
25,000
-8.3%
|
20.03
|
500,668
USD
|
|
|
May 8, 2020 |
May 6, 2020 |
PS
Planned sale
|
PATTERSON LEONE D
CEO, President and Director
Executive Director
|
20,000
-13.9%
20.02
400,400
USD
|
20,000
-13.9%
|
20.02
|
400,400
USD
|
|
|
May 20, 2020 |
May 5, 2020 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
10,000
-3.5%
16.26
162,573
USD
|
10,000
-3.5%
|
16.26
|
162,573
USD
|
|
|
March 25, 2020 |
March 20, 2020 |
PS
Planned sale
|
PATTERSON LEONE D
CEO, President and Director
Executive Director
|
39,526
-24.3%
10.17
401,908
USD
|
39,526
-24.3%
|
10.17
|
401,908
USD
|
|
|
March 18, 2020 |
March 17, 2020 |
PS
Planned sale
|
PATTERSON LEONE D
CEO, President and Director
Executive Director
|
474
-0.3%
10.02
4,749
USD
|
474
-0.3%
|
10.02
|
4,749
USD
|
|
|
Feb. 20, 2020 |
Feb. 18, 2020 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
5,000
-1.9%
16.23
81,156
USD
|
5,000
-1.9%
|
16.23
|
81,156
USD
|
|
|
Feb. 14, 2020 |
Feb. 14, 2020 |
B
Purchase
|
Scopa James Paul
Non-Executive Director
|
10,000
+50.0%
13.75
137,500
USD
|
10,000
+50.0%
|
13.75
|
137,500
USD
|
|
|
Feb. 14, 2020 |
Feb. 12, 2020 |
PS
Planned sale
|
Gasmi Mehdi
Non-Executive Director
|
10,000
-3.7%
15.07
150,690
USD
|
10,000
-3.7%
|
15.07
|
150,690
USD
|
|
|
Dec. 26, 2019 |
Dec. 23, 2019 |
PS
Planned sale
|
PATTERSON LEONE D
CEO, President and Director
Executive Director
|
40,000
-14.9%
10.72
428,800
USD
|
40,000
-14.9%
|
10.72
|
428,800
USD
|
|
|
May 6, 2019 |
May 6, 2019 |
B
Purchase
|
Scopa James Paul
Non-Executive Director
|
20,000
+inf%
6.71
134,200
USD
|
20,000
+inf%
|
6.71
|
134,200
USD
|
|
|
June 17, 2015 |
June 15, 2015 |
PS
Planned sale
|
Gasmi Mehdi
SVP,Pharmaceutical Development
Officer
|
500
-6.7%
39.86
19,931
USD
|
500
-6.7%
|
39.86
|
19,931
USD
|
|
|
June 15, 2015 |
June 12, 2015 |
PS
Planned sale
|
Bain Linda
Chief Financial Officer
Officer
|
3,500
-28.0%
39.94
139,795
USD
|
3,500
-28.0%
|
39.94
|
139,795
USD
|
|
|
June 11, 2015 |
June 10, 2015 |
PS
Planned sale
|
Chalberg Thomas W.
Chief Executive Officer
Executive Director
|
6,995
-2.6%
38.90
272,123
USD
|
6,995
-2.6%
|
38.90
|
272,123
USD
|
|
|
June 11, 2015 |
June 10, 2015 |
PS
Planned sale
|
Chalberg Thomas W.
Chief Executive Officer
Executive Director
|
12,970
-4.6%
38.04
493,339
USD
|
12,970
-4.6%
|
38.04
|
493,339
USD
|
|
|
June 11, 2015 |
June 10, 2015 |
PS
Planned sale
|
Blumenkranz Mark S.
Non-Executive Director
|
600
-0.1%
39.91
23,948
USD
|
600
-0.1%
|
39.91
|
23,948
USD
|
|
|
June 11, 2015 |
June 9, 2015 |
PS
Planned sale
|
Blumenkranz Mark S.
Non-Executive Director
|
200
-0.0%
37.35
7,470
USD
|
200
-0.0%
|
37.35
|
7,470
USD
|
|
|
June 11, 2015 |
June 9, 2015 |
PS
Planned sale
|
Blumenkranz Mark S.
Non-Executive Director
|
7,000
-1.3%
36.20
253,402
USD
|
7,000
-1.3%
|
36.20
|
253,402
USD
|
|
|
June 10, 2015 |
June 8, 2015 |
PS
Planned sale
|
Gasmi Mehdi
VP, Pharmaceutical Development
Officer
|
82
-1.2%
39.88
3,270
USD
|
82
-1.2%
|
39.88
|
3,270
USD
|
|
|
June 10, 2015 |
June 8, 2015 |
PS
Planned sale
|
Gasmi Mehdi
VP, Pharmaceutical Development
Officer
|
183
-2.5%
38.95
7,128
USD
|
183
-2.5%
|
38.95
|
7,128
USD
|
|
|
June 10, 2015 |
June 8, 2015 |
PS
Planned sale
|
Gasmi Mehdi
VP, Pharmaceutical Development
Officer
|
235
-3.1%
37.97
8,923
USD
|
235
-3.1%
|
37.97
|
8,923
USD
|
|
|
June 10, 2015 |
June 8, 2015 |
PS
Planned sale
|
Wachter Paul
Non-Executive Director
|
176
-0.5%
39.88
7,019
USD
|
176
-0.5%
|
39.88
|
7,019
USD
|
|
|
June 10, 2015 |
June 8, 2015 |
PS
Planned sale
|
Wachter Paul
Non-Executive Director
|
475
-1.2%
38.96
18,505
USD
|
475
-1.2%
|
38.96
|
18,505
USD
|
|
|
June 5, 2015 |
June 4, 2015 |
PS
Planned sale
|
Hull Hans
SVP, Business Operations
Officer
|
2,000
-15.0%
37.64
75,283
USD
|
2,000
-15.0%
|
37.64
|
75,283
USD
|
|
|
June 2, 2015 |
June 1, 2015 |
PS
Planned sale
|
Schwartz Steven Daniel
Non-Executive Director
|
3,093
-0.8%
36.81
113,854
USD
|
3,093
-0.8%
|
36.81
|
113,854
USD
|
|
|
June 2, 2015 |
June 1, 2015 |
PS
Planned sale
|
Wachter Paul
Non-Executive Director
|
210
-0.5%
36.81
7,730
USD
|
210
-0.5%
|
36.81
|
7,730
USD
|
|
|
May 29, 2015 |
May 28, 2015 |
PS
Planned sale
|
Gasmi Mehdi
VP, Pharmaceutical Development
Officer
|
500
-6.7%
38.02
19,009
USD
|
500
-6.7%
|
38.02
|
19,009
USD
|
|
|
May 27, 2015 |
May 26, 2015 |
PS
Planned sale
|
Wachter Paul
Non-Executive Director
|
102
-0.2%
38.30
3,906
USD
|
102
-0.2%
|
38.30
|
3,906
USD
|
|
|
May 27, 2015 |
May 26, 2015 |
PS
Planned sale
|
Wachter Paul
Non-Executive Director
|
304
-0.7%
37.59
11,428
USD
|
304
-0.7%
|
37.59
|
11,428
USD
|
|
|
May 22, 2015 |
May 22, 2015 |
PS
Planned sale
|
Schwartz Steven Daniel
Non-Executive Director
|
5,196
-1.3%
38.88
202,043
USD
|
5,196
-1.3%
|
38.88
|
202,043
USD
|
|
|
May 22, 2015 |
May 21, 2015 |
PS
Planned sale
|
Gasmi Mehdi
VP, Pharmaceutical Development
Officer
|
500
-6.7%
38.87
19,435
USD
|
500
-6.7%
|
38.87
|
19,435
USD
|
|
|
May 21, 2015 |
May 19, 2015 |
PS
Planned sale
|
Blumenkranz Mark S.
Non-Executive Director
|
1,000
-8.7%
36.91
36,911
USD
|
1,000
-8.7%
|
36.91
|
36,911
USD
|
|
|
May 21, 2015 |
May 19, 2015 |
PS
Planned sale
|
Blumenkranz Mark S.
Non-Executive Director
|
1,000
-8.7%
36.91
36,911
USD
|
1,000
-8.7%
|
36.91
|
36,911
USD
|
|
|
May 18, 2015 |
May 15, 2015 |
PS
Planned sale
|
Blumenkranz Mark S.
Non-Executive Director
|
4,525
-0.8%
36.00
162,886
USD
|
4,525
-0.8%
|
36.00
|
162,886
USD
|
|
|
May 15, 2015 |
May 14, 2015 |
PS
Planned sale
|
Gasmi Mehdi
VP, Pharmaceutical Development
Officer
|
500
-6.7%
35.31
17,656
USD
|
500
-6.7%
|
35.31
|
17,656
USD
|
|
|
May 13, 2015 |
May 13, 2015 |
PS
Planned sale
|
Bain Linda
Chief Financial Officer
Officer
|
285
-3.1%
34.94
9,959
USD
|
285
-3.1%
|
34.94
|
9,959
USD
|
|
|
May 12, 2015 |
May 11, 2015 |
PS
Planned sale
|
Bain Linda
Chief Financial Officer
Officer
|
715
-7.4%
34.91
24,964
USD
|
715
-7.4%
|
34.91
|
24,964
USD
|
|
|
May 12, 2015 |
May 11, 2015 |
PS
Planned sale
|
Wachter Paul
Non-Executive Director
|
132
-0.3%
34.29
4,527
USD
|
132
-0.3%
|
34.29
|
4,527
USD
|
|
|
May 12, 2015 |
May 11, 2015 |
PS
Planned sale
|
Wachter Paul
Non-Executive Director
|
552
-1.3%
33.70
18,604
USD
|
552
-1.3%
|
33.70
|
18,604
USD
|
|
|
May 8, 2015 |
May 7, 2015 |
PS
Planned sale
|
Gasmi Mehdi
VP, Pharmaceutical Development
Officer
|
500
-6.7%
33.28
16,638
USD
|
500
-6.7%
|
33.28
|
16,638
USD
|
|
|
May 6, 2015 |
May 4, 2015 |
PS
Planned sale
|
Hull Hans
SVP, Business Operations
Officer
|
5,000
-30.6%
30.87
154,349
USD
|
5,000
-30.6%
|
30.87
|
154,349
USD
|
|
|
May 6, 2015 |
May 4, 2015 |
PS
Planned sale
|
Bain Linda
Chief Financial Officer
Officer
|
2,500
-21.7%
31.59
78,972
USD
|
2,500
-21.7%
|
31.59
|
78,972
USD
|
|
